key: cord-0940481-u0zb1exz
authors: Domon, Hisanori; Maekawa, Tomoki; Isono, Toshihito; Furuta, Kazuyuki; Kaito, Chikara; Terao, Yutaka
title: Proteolytic cleavage of HLA class II by human neutrophil elastase in pneumococcal pneumonia
date: 2021-01-28
journal: Sci Rep
DOI: 10.1038/s41598-021-82212-5
sha: 9119cef47c253ceb198d3a0f809ec0803f827c22
doc_id: 940481
cord_uid: u0zb1exz

Bacterial and viral respiratory infections can initiate acute lung injury and acute respiratory distress syndrome. Neutrophils and their granule enzymes, including neutrophil elastase, are key mediators of the pathophysiology of acute respiratory failure. Although intracellular neutrophil elastase functions as a host defensive factor against pathogens, its leakage into airway spaces induces degradation of host connective tissue components. This leakage disrupts host innate immune responses via proteolytic cleavage of Toll-like receptors and cytokines. Here, we investigated whether neutrophils possess proteases that cleave adaptive immune molecules. We found that expression of the human leukocyte antigen (HLA) class II molecule HLA-DP β1 was decreased in THP-1-derived macrophages treated with supernatants from dead neutrophils. This decreased HLA-DP β1 expression was counteracted by treatment with neutrophil elastase inhibitor, suggesting proteolytic cleavage of HLA-DP β1 by neutrophil elastase. SDS-PAGE showed that neutrophil elastase cleaved recombinant HLA-DP α1, -DP β1, -DQ α1, -DQ β1, -DR α, and -DR β1. Neutrophil elastase also cleaved HLA-DP β1 on extracellular vesicles isolated from macrophages without triggering morphological changes. Thus, leakage of neutrophil elastase may disrupt innate immune responses, antigen presentation, and T cell activation. Additionally, inhibition of neutrophil elastase is a potential therapeutic option for treating bacterial and viral pneumonia.

www.nature.com/scientificreports/ elastin, proteoglycan, fibronectin and several collagen types, resulting in tissue destruction 14 . We previously demonstrated that S. pneumoniae produces pneumolysin (PLY), a pore-forming toxin, which leads to neutrophil lysis and induces NE leakage 15 . Subsequently, extracellular NE cleaves several host proteins associated with the innate immune response, including pulmonary surfactant protein D 16 , C5a receptor 17 , Toll-like receptors, and proinflammatory cytokines 18 . However, the consequences of leakage of neutrophil serine proteases on the adaptive immune system are not fully understood.

Understanding the physiological activity of granule enzyme and its role may lead to better treatments for acute pulmonary failure. As NE cleaves multiple host cell-surface molecules, we hypothesized that neutrophil cell death promotes the cleavage of major histocompatibility complex (MHC) class II proteins. Therefore, the main objective of this study was to investigate the effect of supernatants from dead neutrophils on MHC class II expression on macrophages.

HLA class II expression is decreased on human macrophages treated with culture supernatants from pore-forming toxin-treated neutrophils. We first investigated whether neutrophils leak proteases that cleave HLA class II. Accordingly, primary isolated human neutrophils were pretreated with PLY; the supernatant from dead neutrophils was added to THP-1-derived macrophages (hereafter designated as macrophages). The fluorescence intensity of HLA-DP β1, a class II β-chain, was decreased in macrophages treated with supernatants from dead neutrophils compared to after treatment with supernatants from untreated neutrophils (Fig. 1a,b) . We hypothesized that NE leakage induces cleavage of HLA class II and investigated the effect of the NE inhibitor sivelestat sodium hydrate (SSH) on HLA-DP β1 expression. As shown in Fig. 1c 18 . Thus, we treated human macrophages with up to 300 mU/mL of hNE. Immunofluorescence confocal microscopy and Western blotting indicated that 300 mU/mL hNE significantly decreased the intensity of HLA-DP β1 on macrophages (Fig. 2a-d) . However, treatment with 300 mU/mL hNE affected neither gene transcription of HLA class II-related genes (HLA-DPB1, HLA-DQB1, and HLA-DRA; Supplementary Fig. S1 online) nor cell viability in macrophages 18 . Overall, our findings suggest that hNE in the supernatant from PLY-treated neutrophils cleaves HLA-DP β1 on macrophages.

hNE cleaves not only HLA-DP β1, but also HLA-DQ and HLA-DR. HLA class II genes are composed of three closely linked subregions encoding the polymorphic HLA class II molecules HLA-DP, -DQ, and -DR 19 . We investigated whether hNE cleaves recombinant (r) HLA class II molecules rHLA-DP α1, -DP β1, -DQ α1, -DQ β1, -DR α, and -DR β1. SDS-PAGE showed that all of these molecules had almost disappeared after 3-h treatment with 300 mU/mL NE (Fig. 3) . Additionally, rHLA-DP β1, -DR α, and -DR β1 exhibited lowermolecular-mass fragments upon hNE treatment. These findings indicate that hNE cleaves multiple HLA class II molecules, which in turn results in decreased HLA class II expression on macrophages.

hNE cleaves HLA class II on extracellular vesicles. Reportedly, antigen-presenting cells (APCs) secrete exosomes that carry peptide-loaded HLA molecules that can stimulate T-cell proliferation in vitro 20, 21 . In addition, exosomes, which express HLA class II and co-stimulatory molecules, are present in the BALF obtained from healthy individuals, suggesting that they play a role in antigen delivery or immune regulation during airway antigen exposure 22 . Based on this, we examined whether hNE-treatment affects HLA class II expression on extracellular vesicles. Supplementary Fig. S2 shows the characterization of extracellular vesicles isolated from show that the protein bands representing HLA-DP β1 on extracellular vesicles isolated from hNE-treated macrophages were significantly decreased in intensity relative to those from untreated macrophages. Enzyme-linked immunosorbent assay (ELISA) demonstrated that the concentration of extracellular vesicles was only marginally decreased in the supernatant from 300 mU/mL hNE-treated macrophages (Fig. 4c) . These data suggest two hypotheses: (i) hNE directly cleaves HLA-DP β1 on extracellular vesicles; (ii) hNE-induced cleavage of HLA-DP β1 on macrophages results in release of extracellular vesicles that express lower levels of the molecule. To clarify the effect of hNE on HLA-DP β1 expression on extracellular vesicles, we isolated extracellular vesicles from untreated macrophages and then exposed the vesicles to hNE followed by Western blotting with anti-HLA-DP β1 antibody. To determine whether the antibody nonspecifically detects other proteins such as pneumococcal proteins, BALF from SJL/J mice upon intratracheal infection with pneumococcus were also analyzed by immunoblotting. Supplementary Fig. S4 shows that the anti-MHC class II antibody was not specific for BALF from SJL/J mice, indicating the high specificity of the antibody. These findings suggest that murine (m) NE cleaves mMHC class II, resulting in detection of MHC class II fragments in the BALF from a model of intratracheal pneumococcal infection.

Pulmonary host defense responses involve both innate and adaptive immune responses. Innate defenses consist of structural defenses, antimicrobial molecules, and phagocytic defenses provided by resident alveolar macrophages and neutrophils that are recruited into the lung in response to infection 24 . In our previous studies, we demonstrated that S. pneumoniae PLY induces neutrophil lysis and NE leakage, which results in disruption of alveolar epithelial cells, impaired phagocytic activity in macrophages, and proteolytic cleavage of innate immune components, including Toll-like receptors and proinflammatory cytokines 15, 18 . Here, we addressed the intriguing possibility that at least some adaptive immune molecules, such as HLA class II molecules, on APCs and extracellular vesicles are cleaved by hNE, which was originally identified as a major granule enzyme contributing to host defense against bacterial infection. Overall, leakage of hNE may disrupt not only innate immune responses, but also antigen presentation and T-cell activation. The adaptive immune system is distinguished by its ability to respond specifically to an almost limitless number of antigens. A key requirement for generating such immune responses involves the display of antigenic www.nature.com/scientificreports/ peptides on the cell surface by MHC class I and class II. Subsequently, antigen/MHC complexes induce the activation, expansion, and differentiation of T cells into multiple effectors 25 . In addition to neutrophils, T cells rapidly infiltrate into areas of inflamed lung tissue following infection of S. pneumoniae 26 . Additionally, MHC class II knockout mice in a model of pneumococcal pneumonia and septicemia showed increased bacterial colony-forming units in the lung tissue and blood, respectively, compared with their wild-type counterparts. A recent study showed that patients with coronavirus disease 2019 pneumonia who developed ARDS exhibited significantly higher neutrophil counts compared to those without ARDS 27 . The study also suggested that higher CD4 + T cell counts protect patients from ARDS. These reports indicate the importance of antigen presentation and subsequent CD4 + T-cell activation for inducing protective immunity against bacterial and viral pneumonia 28 . Therefore, hNE leakage-induced cleavage of HLA molecules may inhibit CD4 + T-cell activation, downregulate cytokine production, and exacerbate severe pneumonia associated with ALI and ARDS. Furthermore, we previously showed that hNE degrades multiple cytokines, including interferon gamma, interleukin (IL)-2, IL-4, and IL-12, suggesting that hNE attenuates multiple adaptive immune responses 18 . These in vitro findings prompted us to test whether APCs pretreated with hNE impair T-cell activation. However, contrary to the hypothesis, coculture of hNE-pretreated mouse bone marrow dendritic cells with 3A9 T cells showed increased IL-2 in the supernatant compared with in the untreated control ( Supplementary Fig. S5a  online) . Flow cytometry showed that hNE treatment decreased the expression of mouse PD-L1 and PD-L2 on dendritic cells ( Supplementary Fig. S5b online) , suggesting that hNE cleaves only co-inhibitory molecules on murine APCs, followed by increased activation of T cells. In this context, we previously reported that hNE cleaves human tumor necrosis factor, although murine tumor necrosis factor was not cleaved by hNE in vitro 18 . However, an in vivo mouse intratracheal infection model suggested that mNE cleaves mMHC class II. These results indicate a molecular basis for distinctions in peptide substrate specificities between hNE and mNE, despite their conserved catalytic triad, His, Asp, and Ser 29 . Kalupov et al. reported that mNE did not cleave hNE-specific substrates 30 . They also identified structural differences between mNE and hNE that may account for their differences in substrate specificity. Therefore, there are limitations to using murine cell lines and murine infection models to evaluate the molecular harmfulness of NE in human inflammatory diseases.

In the present study, hNE directly cleaved HLA class II on extracellular vesicles and the intensity of the protein band decreased to approximately 40% in Fig. 4d ,e. However, Fig. 4a,b show that HLA-DP β1 expression on extracellular vesicles isolated from hNE-treated macrophages were almost completely absent. These data suggest that hNE-induced cleavage of HLA class II on macrophages may result in release of extracellular vesicles that express lower levels of the molecule. It has been reported that newly synthesized MHC class II complexes are transferred from trans-Golgi network to the plasma membrane 31 . Following endocytosis, MHC class II complexes are internalized and traffic to antigen-processing compartments, which contain intraluminal vesicles 32 . Some of MHC class II complexes are sorted into the intraluminal vesicles. Thereafter, the vesicles are released into the extracellular space and secreted vesicles are termed extracellular vesicles 33 . These observations indicate that, following exposure to hNE, MHC class II complexes are sorted into the vesicles during lung infection. Therefore, it is possible that hNE-mediated cleavage of MHC class II on macrophages results in the decreased MHC class II expression on extracellular vesicles.

Several studies investigated the potential role of various NE inhibitors, including sivelestat, in bacterial pneumonia 34 . In murine models of severe pneumococcal pneumonia, the administration of sivelestat resulted in higher survival rates and decreased bacterial counts in the blood 18, 35 . These data suggest that NE-induced lung injury and immune subversion result in bacterial invasion of the bloodstream. Furthermore, the number of S. pneumoniae in BALF was also decreased by sivelestat treatment both in murine and hamster models of pneumonia 18, 36 . Although there is a possibility that intracellular pneumococcal killing in neutrophils may be partially suppressed by NE inhibition 10 , impairment of phagocytic activity in macrophage and disruption of pulmonary epithelial barrier induced by extracellular NE is counteracted by sivelestat 15 . Taken together, in addition to antibiotic treatment, NE inhibitor is a potential therapeutic option for treating pneumococcal pneumonia.

In conclusion, our data suggest that hNE leakage disrupts host adaptive immunity. Generally, hNE-induced proteolytic degradation of host tissues is inhibited by serum α1-antitrypsin, a serine protease inhibitor. However, in response to microbial invasion, neutrophils also release matrix metalloproteinases that degrade and inactivate α1-antitrypsin, increasing proteolytic activity of hNE, causing ALI 37 . Collectively, these observations suggest that improved therapeutic strategies for pneumonia require inhibition of elastase activity in the lung. Human neutrophil isolation and supernatant preparation. Neutrophils were prepared as previously described 38 Proteolytic cleavage analysis. Whole-cell lysates of hNE-treated or untreated macrophages were prepared in Protein Extraction Reagent (Thermo Fisher Scientific). Enrichment of extracellular vesicles from the culture supernatant of macrophages is described in the supplementary information. The samples were mixed with SDS-sample buffer, separated by SDS-PAGE, and transferred to polyvinylidene difluoride membranes (Merck KGaA, Darmstadt, Germany), followed by incubation with blocking reagent (Nacalai Tesque, Kyoto, Japan). The membrane was probed with an anti-MHC class II (HLA-DP β1) antibody or anti-glyceraldehyde 3-phosphate dehydrogenase antibody (Abcam) and then incubated with a horseradish peroxidase-conjugated secondary antibody (Cell Signaling Technology, Danvers, MA, USA) in Tris-buffered saline containing 0.05% Tween 20. The membrane was treated with horseradish peroxidase substrates (GE Healthcare, Little Chalfont, UK) and analyzed with a chemiluminescence detector (Fujifilm, Tokyo, Japan). The intensity of the signal was quantified using Image Studio software version 5.2 (LI-COR Bioscience, Lincoln, NE, USA). For the recombinant protein cleavage assay, 400-1000 ng of rHLA-DP α1, rHLA-DP β1, rHLA-DQ α1, rHLA-DQ β1, rHLA-DR α, and rHLA-DR β1 were treated with 300 mU/mL hNE at 37 °C for 3 h and mixed with SDS-sample buffer. All samples were separated by SDS-PAGE followed by Coomassie brilliant blue staining (APRO Science, Tokushima, Japan).

The extracellular vesicles level in the macrophage supernatant was determined using the CD9/CD63 human exosome ELISA Kit (Cosmo Bio, Tokyo, Japan).

Details of the pneumococcal culture and mouse model of intratracheal pneumococcal infection were described previously 18, 39 , and additional information can be found in the supplementary information. All animal experiments were approved by the Institutional Animal Care and Use Committee of Niigata University (Approval number: SA00002). We confirmed that all experiments were performed in accordance with relevant guidelines and regulations. Statistical analysis. Data were statistically analyzed by one-way analysis of variance with Tukey's or Dunnett's multiple-comparison test using Graph Pad Prism version 7.05 (GraphPad Software, Inc., La Jolla, CA, USA).

All data described are contained within the manuscript.

Acute lung injury and the acute respiratory distress syndrome: pathophysiology and treatment

Acute lung injury and acute respiratory distress syndrome

The acute respiratory distress syndrome

Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome

Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection

Neutrophils are needed for an effective immune response against pulmonary rat coronavirus infection, but also contribute to pathology

Neutrophil extracellular traps kill bacteria

Extended cleavage specificity of human neutrophil elastase, human proteinase 3, and their distant ortholog clawed frog PR3-three elastases with similar primary but different extended specificities and stability

Degradation of outer membrane protein A in Escherichia coli killing by neutrophil elastase

Human neutrophils kill Streptococcus pneumoniae via serine proteases

IL-8 and neutrophil elastase levels in the respiratory tract of infants with RSV bronchiolitis

Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma

Elastase-mediated activation of the severe acute respiratory syndrome coronavirus spike protein at discrete sites within the S2 domain

Physiology and pathophysiology of neutral proteinases of human granulocytes

Streptococcus pneumoniae disrupts pulmonary immune defence via elastase release following pneumolysindependent neutrophil lysis

Neutrophil serine proteinases inactivate surfactant protein D by cleaving within a conserved subregion of the carbohydrate recognition domain

Mechanism of neutrophil dysfunction: neutrophil serine proteases cleave and inactivate the C5a receptor

Neutrophil elastase subverts the immune response by cleaving toll-like receptors and cytokines in pneumococcal pneumonia

HLA class II molecules (HLA-DR, -DP, -DQ) on cells in the human CNS studied in situ and in vitro

B lymphocytes secrete antigen-presenting vesicles

Antigen presentation by extracellular vesicles from professional antigen-presenting cells

Exosomes with major histocompatibility complex class II and co-stimulatory molecules are present in human BAL fluid

A shared alloantigenic determinant on Ia antigens encoded by the I-A and I-E subregions: evidence for I region gene duplication

Innate immunity and pulmonary host defense

Cutting antigenic peptides down to size

Host cellular immune response to pneumococcal lung infection in mice

Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan

CD4-T-lymphocyte interactions with pneumolysin and pneumococci suggest a crucial protective role in the host response to pneumococcal infection

Characterization of the mouse neutrophil elastase gene and localization to chromosome 10

Structural characterization of mouse neutrophil serine proteases and identification of their substrate specificities: relevance to mouse models of human inflammatory diseases

AP2 clathrin adaptor complex, but not AP1, controls the access of the major histocompatibility complex (MHC) class II to endosomes

The ins and outs of MHC class II-mediated antigen processing and presentation

T cell-induced secretion of MHC class II-peptide complexes on B cell exosomes

The role of neutrophil elastase inhibitors in lung diseases

Effects of specific neutrophil elastase inhibitor, sivelestat sodium hydrate, in murine model of severe pneumococcal pneumonia

Inhibition of neutrophil elastase reduces lung injury and bacterial count in hamsters

Human neutrophil collagenase cleaves alpha 1-antitrypsin

Aggregatibacter actinomycetemcomitans induces detachment and death of human gingival epithelial cells and fibroblasts via elastase release following leukotoxin-dependent neutrophil lysis

Antibacterial activity of hinokitiol against both antibiotic-resistant and -susceptible pathogenic bacteria that predominate in the oral cavity and upper airways

We thank Dr. Maki Touma (Niigata University, Niigata, Japan) for discussion and constructive suggestions.

H.D. and Y.T. designed the study. H.D., T.M., T.I., K.F., and C.K. performed all of the experiments. H.D., T.M. and C.K. analyzed the data. H.D. and Y.T. wrote the paper. All authors discussed the results and approved of the manuscript.

This work was supported by the Japan Society for the Promotion of Science KAKENHI Grants (JP20K21671, JP19H03828, JP19K22706, JP20K09903, and JP20H03858), Kobayashi International Scholarship Foundation, and Takeda Science Foundation.

The authors declare no competing interests.

The online version contains supplementary material available at https ://doi. org/10.1038/s4159 8-021-82212 -5.Correspondence and requests for materials should be addressed to Y.T.Reprints and permissions information is available at www.nature.com/reprints.Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creat iveco mmons .org/licen ses/by/4.0/.